Amgen and Generate Biomedicines Announce Multi-Target, Multi-Modality Research Collaboration Agreement
Go back to Amgen and Generate Biomedicines Announce Multi-Target, Multi-Modality Research Collaboration Agreement| Amgen Inc (NASDAQ: AMGN) | Delayed: 383.68 -3.96 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $387.64 | 52 Week High | $176.85 | |||
| Open | $382.00 | 52 Week Low | $133.64 | |||
| Day High | $384.11 | P/E | 57.78 | |||
| Day Low | $379.34 | EPS | $6.64 | |||
| Volume | 545,256 | |||||

